De novo variants in KDM2A cause a syndromic neurodevelopmental disorder
Eric N. Anderson, Ivan Ivanovski, Karen Stals(Royal Devon & Exeter NHS Foundation Trust), Anne M. Comi(Kennedy Krieger Institute), Pia Zacher, Suma P. Shankar(Emory University), Nicolas Chatron, Pauline Monin, Anuradha Venkatakrishnan Chimata(University of Dayton), Devon Bonner, Stephan Drukewitz, Yoann Vial, Séverine Drunat(Délégation Paris 7), Xénia Latypova, Julie S. Cohen(Kennedy Krieger Institute), Sukhleen Kour, Senta Schönnagel, Jennefer Carter, John F. Mantovani, Deirdre Donnelly(Belfast Health and Social Care Trust), Tiong Y. Tan, Pedro A. Sanchez-Lara, et al.(Unknown), Jonathan Levy, Lisa M. Dyer, Deepa S. Rajan, Jonathan A. Bernstein, Alain Verloès(Inserm), Siobhan O'Sullivan, Sureni V. Mullegama
Cited by 0
Related Papers
Evidence for 28 genetic disorders discovered by combining healthcare and research data
|Nature|2020|672
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
|New England Journal of Medicine|2016|555
High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies
|The American Journal of Human Genetics|2017|456